We caught up with Chris Horan, Artiva Biotherapeutics' CTO, to discuss natural killer cell therapies and Artiva’s experiences and strategies with its candidate, AlloNK.
- FDA Publishes Final Guidance On Reporting Listed Drug Amounts
- Digitizing CMC Knowledge Management
- When Does GMP Matter In Non-GMP Settings?
- What Really Happens When A Cell Therapy Supply Chain Fails?
- Designing Highly Agile Bio/Pharma Manufacturing Facilities
- Best Practices For Clinical Supply Chain Management In Rare Disease Trials
- Quick Takes From Takeda Austria’s Annex 1 Rollout
- How To Prevent And Manage Temperature Excursions In Clinical Trials
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
24/7 Cell & Gene Control Tower Provides Agile Solution For Critical Shipments
Get an overview of a successful re-route of six critical shipments to the UK and Spain from Amsterdam used to deliver CAR-T drug products to treat non-Hodgkin’s lymphoma cancer patients.
-
Gain Confidence In Clinical Trial Outcomes
Delve into the ways that smart packaging integrations within clinical trial strategies can improve adherence to dosing protocols and provide a comprehensive understanding of a patient’s exposure.
-
Overcoming Obstacles To Deliver Critical Autologous Cell Therapy
See how teams ensured a seamless route, including on-time customs clearance and delivery of autologous cell therapy, from the U.S. to a manufacturing site in Germany
-
Ensuring On-Time Release Of CAR-T Cell Treatment In Spain
Due to the COVID-19 pandemic, and the start of Brexit, a CAR-T cell treatment therapy shipment was offloaded multiple times by the airline, requiring an alternative transport solution.
-
Optimizing IRT For Clinical Supply Management
Experts speak on supply capabilities within interactive response technology (IRT) – how flexibility is important to functionality and who to involve and which questions to ask in optimizing IRT for clinical supply.
-
Blinded Randomization And Trial Supply Management Gets Support
Uncover how this global specialty pharmaceutical company was able to ensure the confidentiality of its blinded study data while receiving flexible and scalable unblinded support.
-
Optimized Laboratory Kitting Is Key To Successful Clinical Trials
Clinical trials can be completely derailed by the absence of a single component, a lack of clarity in labelling, or errors in temperature-controlled logistics.
-
Build A Foundation For Successful Clinical Manufacturing
Establishing both the QTPP and CQA for your drug at the beginning of the product lifecycle is crucial for a successful GMP manufacturing process.
-
Investigational Medicinal Products: Labeling Changes And Their Implications
Learn about Annex VI, which covers changes in the labeling requirements for investigational medicinal products (IMPs) and harmonizes them throughout EU countries.
-
Technology Solutions That Help Optimize Clinical Trial Distribution And Supply
Explore how interactive response technology (IRT) can solve some common challenges of manually managed clinical trials and how to find the best IRT solution that meets clinical trial requirements.
CATALENT CORNER
Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.